Members of the Board of Directors are organizational stewards who are passionate about endocrine research and practice and are committed to our mission – to unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide. To learn more about this dynamic group of leaders, please review their bios. If you’d like to become a member leader, learn more today.

Officers

E. Dale Abel, MD, PhD

President
E. Dale Abel, MD, PhD
University of Iowa
Term end: 2021

Gary Hammer, MD, PhD

President-elect
Gary Hammer, MD, PhD
University of Michigan
Term end: 2022

Immediate Past President
Susan J. Mandel, MD, MPH
University of Pennsylvania
Term end: 2020

Secretary/Treasurer
Dolores M. Shoback, MD
University of California, San Francisco
Term end: 2022

Directors

Henry Anhalt, DO
Science37
Private Practice
Term end: 2021

Cesar L. Boguszewski, MD, PhD
Federal University of Parana
Term end: 2020

Samantha Butts, MD
University of Pennsylvania
Term end: 2022

Ann Danoff, MD
CMCVAMC & Perelman School of Medicine
Term end: 2021

Ghada El-Hajj Fuleihan, MD, MPH
American University of Beirut
Term end: 2022

Whitney Goldner, MD
University of Nebraska Medical Center
Term end: 2022

Anthony Hollenberg, MD
Weill Cornell Medicine
Term end: 2020

Genevieve Neal-Perry, MD, PhD
University of Washington
Term end: 2020
Clifford Rosen, MD
Tufts University
Term end: 2020


Stephen M. Rosenthal, MD
University of California, San Francisco
Term end: 2021

Joy Wu, MD, PhD
Stanford University
Term end: 2022

Ex-Officio Members

Ex-Officio, Early Career Member
Lori Raetzman, PhD
University of Illinois
Term end: 2020

Ex-Officio, Nominating Committee Chair
Cherié Butts, PhD
Biogen Inc.
Term end: 2020

Ex-Officio, CEO
Barbara Byrd Keenan, FASAE, CAE
Endocrine Society